Best Practice & Research Clinical Rheumatology
Volume 23, Issue 1 , Pages 93-102, February 2009

Drug management of early rheumatoid arthritis – 2008☆

  • Tuulikki Sokka, MD, PhD

      Affiliations

    • Jyväskylä Central Hospital, 40620 Jyväskylä, Finland
    • Medcare Oy, Äänekoski, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 40 735 2087; Fax: +358 14 2691 275.
    • ,
  • Heidi Mäkinen, MD

      Affiliations

    • Jyväskylä Central Hospital, 40620 Jyväskylä, Finland
    • Tampere University Hospital, Tampere, Finland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Modified and updated from: 1. Sokka T, Envalds M, Pincus T. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol. 2008 Apr 25. 2. Sokka T, Hannonen P, Möttönen T. Conventional disease-modifying antirheumatic drugs in early arthritis. Rheum Dis Clin North Am. 2005 Nov;31(4):729-44. Review.

PII: S1521-6942(08)00091-0

doi:10.1016/j.berh.2008.08.003

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 1 , Pages 93-102, February 2009

Article Tools